{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:43:44Z","timestamp":1791146624412,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.bbamem.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T08:01:29Z","timestamp":1352361689000},"page":"249-259","source":"Crossref","is-referenced-by-count":42,"title":["Plantaricin A, a cationic peptide produced by Lactobacillus plantarum, permeabilizes eukaryotic cell membranes by a mechanism dependent on negative surface charge linked to glycosylated membrane proteins"],"prefix":"10.1016","volume":"1828","author":[{"given":"Sverre L.","family":"Sand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Nissen-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trude M.","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2012.11.001_bb0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1432-1033.2003.03451.x","article-title":"Distinguishing between different pathways of bilayer disruption by the related antimicrobial peptides cecropin B, B1 and B3","volume":"270","author":"Chen","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/psc.699","article-title":"Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action","volume":"11","author":"Fimland","year":"2005","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002030050418","article-title":"Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action","volume":"167","author":"Nissen-Meyer","year":"1997","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-4165(97)00024-X","article-title":"Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells","volume":"1336","author":"Chen","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jb\/mvh114","article-title":"Induction of transient ion channel-like pores in a cancer cell by antibiotic peptide","volume":"136","author":"Ye","year":"2004","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0035","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1073\/pnas.88.9.3792","article-title":"Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation","volume":"88","author":"Cruciani","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0040","first-page":"197","article-title":"Potential therapeutic applications of magainins and other antimicrobial agents of animal origin","volume":"186","author":"Jacob","year":"1994","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.iy.11.040193.000541","article-title":"Defensins: antimicrobial and cytotoxic peptides of mammalian cells","volume":"11","author":"Lehrer","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1172\/JCI115310","article-title":"Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane","volume":"88","author":"Lichtenstein","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0055","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/1381612043383971","article-title":"Membrane disrupting lytic peptides for cancer treatments","volume":"10","author":"Leuschner","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00232-010-9263-4","article-title":"Peptide pheromone plantaricin A produced by Lactobacillus plantarum permeabilizes liver and kidney cells","volume":"235","author":"Andersland","year":"2010","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00232-007-9030-3","article-title":"The bacterial peptide pheromone plantaricin A permeabilizes cancerous, but not normal, rat pituitary cells and differentiates between the outer and inner membrane leaflet","volume":"216","author":"Sand","year":"2007","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0070","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.peptides.2010.04.010","article-title":"Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells","volume":"31","author":"Sand","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/AEM.60.1.160-166.1994","article-title":"The gene encoding plantaricin A, a bacteriocin from Lactobacillus plantarum C11, is located on the same transcription unit as an agr-like regulatory system","volume":"60","author":"Diep","year":"1994","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0080","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1021\/bi981532j","article-title":"Plantaricin A is an amphiphilic alpha-helical bacteriocin-like pheromone which exerts antimicrobial and pheromone activities through different mechanisms","volume":"37","author":"Hauge","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0085","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1128\/AEM.64.6.2269-2272.1998","article-title":"Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A","volume":"64","author":"Anderssen","year":"1998","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0090","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbamem.2006.03.037","article-title":"Interaction of the antimicrobial peptide pheromone plantaricin A with model membranes: implications for a novel mechanism of action","volume":"1758","author":"Zhao","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0095","doi-asserted-by":"crossref","first-page":"22945","DOI":"10.1074\/jbc.M501620200","article-title":"Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A","volume":"280","author":"Kristiansen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0100","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00262-010-0857-6","article-title":"Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide","volume":"59","author":"Berge","year":"2010","journal-title":"Cancer Immunol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0105","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mt.2009.58","article-title":"Oncolytic reovirus effectively targets breast cancer stem cells","volume":"17","author":"Marcato","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/embor.2011.138","article-title":"The fourth front against cancer. The first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies","volume":"12","author":"Hunter","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0115","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","article-title":"Peptide antibiotics","volume":"43","author":"Hancock","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-4157(98)00014-8","article-title":"Magainins as paradigm for the mode of action of pore forming polypeptides","volume":"1376","author":"Matsuzaki","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F","article-title":"Mode of action of linear amphipathic alpha-helical antimicrobial peptides","volume":"47","author":"Oren","year":"1998","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/bip.10260","article-title":"Mode of action of membrane active antimicrobial peptides","volume":"66","author":"Shai","year":"2002","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M","article-title":"Amphipathic, alpha-helical antimicrobial peptides","volume":"55","author":"Tossi","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20042138","article-title":"Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity","volume":"390","author":"Zelezetsky","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cocis.2009.02.004","article-title":"Rationalizing the membrane interactions of cationic amphipathic antimicrobial peptides by their molecular shape","volume":"14","author":"Bechinger","year":"2009","journal-title":"Curr. Opin. Colloid Interface"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/psc.1343","article-title":"Insights into the mechanisms of action of host defence peptides from biophysical and structural investigations","volume":"17","author":"Bechinger","year":"2011","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0155","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/psc.966","article-title":"Aggregation and membrane permeabilizing properties of designed histidine-containing cationic linear peptide antibiotics","volume":"14","author":"Marquette","year":"2008","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.physiol.65.092101.142459","article-title":"Aminophospholipid asymmetry: a matter of life and death","volume":"65","author":"Balasubramanian","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0165","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1021\/bi00010a034","article-title":"Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2","volume":"34","author":"Matsuzaki","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(99)00197-2","article-title":"Why and how are peptide\u2013lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes","volume":"1462","author":"Matsuzaki","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0005-2736(99)00200-X","article-title":"Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides","volume":"1462","author":"Shai","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbamem.2004.11.008","article-title":"Study of structure and orientation of mesentericin Y105, a bacteriocin from Gram-positive Leuconostoc mesenteroides, and its Trp-substituted analogues in phospholipid environments","volume":"1668","author":"Castano","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0185","first-page":"3062","article-title":"Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes","volume":"51","author":"Utsugi","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0049-3848(92)90013-Z","article-title":"Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa\/tissue factor activity and prothrombinase activity","volume":"67","author":"Rao","year":"1992","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0195","first-page":"365","article-title":"Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces","volume":"5","author":"Sugimura","year":"1994","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/09687689409160430","article-title":"Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells","volume":"11","author":"Williamson","year":"1994","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0205","first-page":"124","article-title":"Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and stereologic analysis","volume":"47","author":"Iozzo","year":"1982","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0210","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI4105","article-title":"The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer","volume":"102","author":"Kleeff","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0215","first-page":"5562","article-title":"Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells","volume":"61","author":"Matsuda","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0220","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1074\/jbc.R100039200","article-title":"Hyaluronan-cell interactions in cancer and vascular disease","volume":"277","author":"Toole","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0225","doi-asserted-by":"crossref","first-page":"14533","DOI":"10.1074\/jbc.C600075200","article-title":"Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells","volume":"281","author":"Fears","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.matbio.2006.07.003","article-title":"The role of syndecans in disease and wound healing","volume":"25","author":"Fears","year":"2006","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/0264-6021:3630201","article-title":"The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones","volume":"363","author":"Munesue","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0240","doi-asserted-by":"crossref","first-page":"29730","DOI":"10.1074\/jbc.M202435200","article-title":"Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells","volume":"277","author":"Park","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/bmc.145","article-title":"High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointestinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies","volume":"16","author":"Theocharis","year":"2002","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0925-4439(00)00051-X","article-title":"Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition","volume":"1502","author":"Theocharis","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0255","first-page":"2107","article-title":"Distribution and changes of glycosaminoglycans in neoplasias of rectum","volume":"15","author":"Tsara","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0260","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/endo-82-2-342","article-title":"Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone","volume":"82","author":"Tashjian","year":"1968","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-9-183","article-title":"The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells","volume":"9","author":"Fadnes","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2407-11-116","article-title":"Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells","volume":"11","author":"Fadnes","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamem.2012.11.001_bb0275","doi-asserted-by":"crossref","first-page":"36099","DOI":"10.1074\/jbc.M109.036426","article-title":"A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency","volume":"284","author":"Duchardt","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbamem.2012.11.001_bb0285","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1517\/13543784.15.8.933","article-title":"Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment","volume":"15","author":"Mader","year":"2006","journal-title":"Exp. Opin. Investig. Drugs"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273612003793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273612003793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T19:47:05Z","timestamp":1594842425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273612003793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0005273612003793"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2012.11.001","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}